Acute oxalate nephropathy: exploring the role of excess dietary oxalate intake.
Acute kidney injury
Dialysis
Oxalate nephropathy
Vitamin C
Journal
CEN case reports
ISSN: 2192-4449
Titre abrégé: CEN Case Rep
Pays: Japan
ID NLM: 101636244
Informations de publication
Date de publication:
08 Apr 2024
08 Apr 2024
Historique:
received:
30
01
2024
accepted:
25
03
2024
medline:
8
4
2024
pubmed:
8
4
2024
entrez:
8
4
2024
Statut:
aheadofprint
Résumé
Acute oxalate nephropathy is a rare but important cause of severe acute kidney injury. We report here two cases presenting as unexplained AKI which were confirmed histologically to be due to acute oxalate nephropathy. Dietary oxalate or its precursor vitamin C was the cause of oxalate exposure in both of these cases. While one patient recovered, another continued to need dialysis and succumbed to underlying metastatic cancer. This cause should be suspected in all patients presenting with unexplained AKI, and detailed history about dietary intake of oxalate or vitamin C should be inquired.
Identifiants
pubmed: 38587605
doi: 10.1007/s13730-024-00870-6
pii: 10.1007/s13730-024-00870-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.
Références
Rosenstock JL, Joab TMJ, DeVita MV, et al. Oxalate nephropathy: a review. Clin Kidney J. 2021;15(2):194–204.
doi: 10.1093/ckj/sfab145
pubmed: 35145635
pmcid: 8825217
Cochat P, Liutkus A, Fargue S, et al. Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol. 2006;21(8):1075–81.
doi: 10.1007/s00467-006-0124-4
pubmed: 16810517
Buysschaert B, Aydin S, Morelle J, et al. Etiologies, clinical features, and outcome of oxalate nephropathy. Kidney Int Rep. 2020;5:1503–9.
doi: 10.1016/j.ekir.2020.06.021
pubmed: 32954074
pmcid: 7486173
Lamarche J, Nair R, Peguero A, et al. Vitamin C-induced oxalate nephropathy. Int J Nephrol. 2011;2011:146927. https://doi.org/10.4061/2011/146927 . Epub 2011 Mar 16
Jaeger Ph., Robertson WG. Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol. 2004;98:64–71.
Getting JE, Gregoire JR, Phul A, et al. Oxalate nephropathy due to ‘juicing’: case report and review. Am J Med. 2013;126:768–72.
doi: 10.1016/j.amjmed.2013.03.019
pubmed: 23830537
Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stone. N Engl J Med. 1993;328:833–8
Hellman L, Burns JJ. Metabolism of l -ascorbic acid-1-C 14 in man. J Biol Chem. 1958;230 (2):923–30.
Blanchard J, Tozer TN, Rowland M. Pharmacokinetic perspectives on megadoses of ascorbic acid. Am J Clin Nutr. 1997;66:1165–71.
Thomas LD, Elinder CG, Tiselius HG, et al. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013;173(5):386–8.
doi: 10.1001/jamainternmed.2013.2296
pubmed: 23381591
Harambat J, Fargue S, Acquaviva C, et al. Genotype–phenotype correlation in primary hyperoxaluria type 1: the p.Gly170Arg AGXT mutation is associated with a better outcome. Kidney Int. 2010;77:443–9.
Mukattash TL, Alkhalidy H, Alzu’bi B, et al. Dietary supplements intake during the second wave of COVID-19 pandemic: a multinational Middle Eastern study. Eur J Integr Med. 2022;49:102102. https://doi.org/10.1016/j.eujim.2022.102102 . Epub 2022 Jan 12. PMID: 35039757; PMCID: PMC8754456.